Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2026
Long-term outcomes of Stereotactic MRI-guided adaptive radiotherapy (SMART) for prostate cancer: Results from a real world large patient cohortClaire van Vliet, Shyama U Tetar, Omar Bohoudi, et al.International Journal of Radiation Oncology, Biology, Physics|August 17, 2019
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity ResultsAnna M E Bruynzeel, Shyama U Tetar, Swie S Oei, et al.The New England Journal of Medicine|June 1, 2012
Preoperative chemoradiotherapy for esophageal or junctional cancerP van Hagen, M C C M Hulshof, J J B van Lanschot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.The Lancet. Oncology|August 10, 2015
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialJoel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, et al.Annals of Surgery|November 8, 2014
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survivalA Koen Talsma, Joel Shapiro, Caspar W N Looman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.Pageof 2